Feasibility study into methods for improving the scalability of MICP (Microbially Induced Calcite Precipitation) for the production of Low carbon Precast Tiles and internal cladding systems
Feasibility study into methods for improving the scalability of MICP (Microbially Induced Calcite Precipitation) for the production of Low carbon Precast Tiles and internal cladding systems
批准号:
10067974
负责人:
金额:
$9.37万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2023
资助国家:
英国
项目状态:
已结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cresco uses biotechnology to manufacture low carbon panelling materials for the construction industry. In 2020 Gypsum plasterboard caused 3.5% of the UK's greenhouse gas emissions. We develop sustainable and circular alternatives to interior panelling products. Using a bacterial bio-manufacturing process, we produce low carbon bio-composites utilising industrial waste.Our material is naturally water and fire resistant, hard wearing, utilises high percentages of waste material (60-90% wt). The entire manufacturing process happens at room temperature. Being able to manufacture without the need of high energy heating processes is where the majority of the carbon savings occur compared to traditional alternatives. As the bacterial process is naturally carbon negative, it is even possible to go carbon negative if the chemical feedstock is supplied through green energy chains.The material shows great promise for non-structural internal panelling applications which would have a high impact on the embodied carbon of a building.With the growing green construction materials market (estimated $940 Billion by 2030), low carbon off the shelf solutions promise commercial success and are essential if we are to tackle the 10% of global CO2 emissions caused by the manufacture of construction materials.Having worked on optimising our process for panelling the past year, the market blocker is neither demand, nor material properties, but instead optimisation needed at the moulding stage for commercial scalability. Cresco Ltd. and the Living Construction Research Group (HBBE, Northumbria) will assess the feasibility of 3 different methods for improving the energy and resource efficiency during moulding. This will allow the business to make a decision around which process to select for scaling and develop further through a subsequent larger project. The project will act as a catalyst between Cresco and HBBE to aid the development and delivery of a new and disruptive sustainable biomanufacturing process which would pave the way for implementation of a scalable manufacturing system to produce low carbon bio-composite panels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Incentive and governance schenism study of corporate green washing behavior in China: Based on an integiated view of econfiguration of environmental authority and decoupling logic
-
批准号:--
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:YU BYUNGJUN
-
依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
-
批准号:82371102
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:苏蕴
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
含Re、Ru先进镍基单晶高温合金中TCP相成核—生长机理的原位动态研究
-
批准号:52301178
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:夏万顺
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
-
批准号:82371150
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯书乐
-
依托单位: